Financial Overview and Strategic Insights
Overall, Spinach is the #2 (1)
cannabis brand
Spinach
WE HAVE SIGNIFICANT UNDERAPPRECIATED VALUE
$862 million in cash and cash equivalents and zero debt (2)
Our Canadian business reached $64.7 million in revenue in 2023 (2)
In edibles, the #1 (1) brand
In flower, the #1 (1) brand
In pre-rolls, the #8 (1) brand
and quickly taking share
In vape, the #3 (1) brand,
and also gaining ground.
We have a leading brand in Israel, totalling revenue of $21.1 million in 2023 (2)
We have an approximate
5.9% stake in PharmaCann,
one of the largest private
U.S. MSOs. Our stake is
currently on our books for
$25.7 million. (2)
PHARMACANN
Additional Investments/Assets / Partnerships
We have an approximate
10% stake in Vitura, a
leading publicly-traded
Australian medical
cannabis provider, worth
approximately $9.6 million.
as of Q4 2023. (2)
VITURA
We own 50% of the equity
in Cronos Grow Co, which is
profitable. We ended the
quarter with a remaining
balance of approximately
$83 million on our
combined loans to Grow Co
and its partners. (2)
CRONOS
GROWCO
We have a growing
portfolio of proprietary
fermentation methods,
product formulations and
genetics.
Spinac
до
PEACENATURALS
MEDICINAL CANNABIS
We have an exclusive
partnership with Altria on a
global basis.
Altria
SOURCE: (1) Hifyre data for the month of December 2023, (2) Cronos public filings
17View entire presentation